Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer

Clinical and Translational Oncology

Volumn 13, Issue 9, 2011, Pages 652-655

  Zikan, Michal ^a   Bohm, Jan ^b   Pavlista, David ^a   Cibula, David ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MEDINOS Clinic   (Germany)

Author keywords

BRCA1; BRCA2; Breast cancer; DCIS; LOH; p53

Indexed keywords

ARTICLE; BCL 2 GENE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; COLLAGEN 2A GENE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE OVEREXPRESSION; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; ONCOGENE; PRECANCER; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VEGF GENE; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; NUCLEOTIDE SEQUENCE; PAGET NIPPLE DISEASE; PATHOLOGY; PROTO ONCOGENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, BRCA1; GENES, BRCA2; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM INVASIVENESS;

EID: 84855367163     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0710-1     Document Type: Article

References (20)

1. Allred DC, Wu Y, Mao S et al (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14:370-378 (Pubitemid 351226103)
2. Hieken TJ, Cheregi J, Farolan M et al (2007) Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with longterm follow-up. Am J Surg 194:504-506 (Pubitemid 47361063)
3. Hieken TJ, Farolan M, D'Alessandro S, Velasco JM (2001) Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery 130:593-600; discussion 600-591
4. Sakorafas GH, Farley DR, Peros G (2008) Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev 34:483-497
5. Abdel-Fatah TM, Powe DG, Hodi Z et al (2008) Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 32:513-523 (Pubitemid 351458293)
6. Farabegoli F, Champeme MH, Bieche I et al (2002) Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol 196:280-286 (Pubitemid 34189416)
7. Zagouri F, Sergentanis TN, Zografos GC (2007) Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J Surg Oncol 5:57
8. Leong AS, Sormunen RT, Vinyuvat S et al (2001) Biologic markers in ductal carcinoma in situ and concurrent infi ltrating carcinoma. A comparison of eight contemporary grading systems. Am J Clin Pathol 115:709-718 (Pubitemid 33051538)
9. Smith KL, Adank M, Kauff N et al (2007) BRCA mutations in women with ductal carcinoma in situ. Clin Cancer Res 13:4306-4310 (Pubitemid 47105995)
10. Hu M, Yao J, Carroll DK et al (2008) Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13:394-406 (Pubitemid 351609443)
11. Shekhar MP, Tait L, Pauley RJ et al (2008) Comedoductal carcinoma in situ: A paradoxical role for programmed cell death. Cancer Biol Ther 7:1774-1782
12. Kataoka N, Cai Q, Wen W et al (2006) Population- based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev 15:1148-1152
13. Viacava P, Naccarato AG, Bocci G et al (2004) Angiogenesis and VEGF expression in preinvasive lesions of the human breast. J Pathol 204:140-146 (Pubitemid 39335286)
14. Pfaffl MW (2001) A new mathematical model for relative quantifi cation in real-time RT-PCR. Nucleic Acids Res 29:e45
15. Pfaffl MW, Horgan GW, Dempfl e L (2002) Relative expression software tool (REST) for groupwise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36
16. Boocock CA, Charnock-Jones DS, Sharkey AM et al (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516
17. Bourgarel-Rey V, Savry A, Hua G et al (2009) Transcriptional down-regulation of Bcl-2 by vinorelbine: identifi cation of a novel binding site of p53 on Bcl-2 promoter. Biochem Pharmacol 78:1148-1156
18. Larson PS, de las Morenas A, Cerda SR et al (2006) Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol 209:307-316 (Pubitemid 43997739)
19. Reis-Filho JS, Lakhani SR (2003) The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 5:313-319
20. Vogl G, Dietze O, Hauser-Kronberger C (2005) Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast. Histopathology 47:617-624 (Pubitemid 41775185)